Mono Antiplatelet and Colchicine Therapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT04949516
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 200 participants
- Sponsor
- Registry
-
NCT04949516
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT04949516. Allocation not applicable; no masking; primary purpose treatment. Start 2021-06-15 (actual); primary completion 2022-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Mono Antiplatelet and Colchicine Therapy
- Acronym
- MACT
- Condition
- Acute Coronary Syndrome
- Condition
- Drug-Eluting Stents
- Intervention (Drug)
- Aspirin
- Intervention (Drug)
- Colchicine
- Lead sponsor
- Wonkwang University Hospital
Record details
- Record id
cardio:ct-nct04949516- Content hash
4d8fd2bbbd10bbe46b25c7e025da8c1809962da6b2f44b955cd33f64bb05e392